Titel: Transparency and Trustworthiness in Drug Development

Termin: 20.8.2018, 9:00 Uhr, bis 24.8.2018, 16:30 Uhr

Veranstaltungsort:
South Campus
Faculty of Law
Karen Blixens Plads 16
DK-2300 Copenhagen S
Denmark

Referenten: Marieke De Bruin (Professor, Director of the Copenhagen Centre for Regulatory Science (CORS), University of Copenhagen) *** Klemens Kappel (Professor, Department of Media, Cognition and Communication, University of Copenhagen) *** Dr. Mark Flear (Senior Lecturer, School of Law, Queens University, Belfast) *** Sofia K. Sporrong (Associate Professor in Social and Clinical Pharmacy, University of Copenhagen) *** Sinan Badakci Sarac (Chief Medical Officer at the Danish Medicines Agency, member of the European Medicines Agency, CHMP) *** Birthe Ryskov (European Rare Diseases, Eurordis Denmark) *** Henrik Harksen (External Associate Professor, Department of Pharmacy, University of Copenhagen) *** Dr. Rosemarie Bernabe (Marie Curie Postdoctoral Fellow, Centre for Medical Ethics, University of Oslo) *** Karen Brøndum-Nielsen (Professor, Chair of the National Committee on Health Research Ethics, Denmark) *** Karin Friis-Bach (Danish Politician, Copenhagen Capital Region) *** Vibeke Bjerregaard (Former Senior Regulatory Affairs Project Manager, Novo Nordisk) *** Dr. Jonathan Ives (Senior Lecturer, Deputy Director - Centre for Ethics in Medicine, Bristol Medical School, University of Bristol)

Weitere Informationen:
https://copenhagensummeruniversity.ku.dk/en/courses/transparency-and-t ...

Kurzbeschreibung: Over the last few decades, complex systems of accountability have been designed to increase transparency and build trustworthy relations between healthcare institutions, the pharmaceutical industry, patients and society as a whole. However, many of these systems have had the converse effect and do not always work as intended.

Dilemmas of transparency and trustworthiness are unavoidable when working in drug development. This course provides a space where you can debate real life cases with relevant stakeholders.
Pharmaceutical ethics awareness enables you to develop innovative ways to increase transparency and trustworthiness throughout the whole life cycle of a medicinal product. Understanding the different stakeholders’ perspectives and dilemmas, will provide you with better tools and arguments to put together a trustworthy regulatory dossier.

Kontakt: Tel.: +45 3533 3423
csu@adm.ku.dk
https://copenhagensummeruniversity.ku.dk/en/

Wissenschaftliche Leitung: Lourdes Cantarero-Arévalo, Associate Professor, Department of Pharmacy, University of Copenhagen.

Schlagworte: Pharmazeutik